Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Panel Pans Avastin Breast Cancer Approval

July 21, 2010 6:29 am | by Matthew Perrone | News | Comments

A panel of cancer experts said that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients.

TOPICS:

GSK Legal Woes Take Toll on Profits

July 21, 2010 6:22 am | by Robert Barr | News | Comments

GlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, reported a loss of $464 million for the second quarter as the company absorbed a hit of $2.4 billion for settling lawsuits.

TOPICS:

Abbott Profits Steady in Second Quarter

July 21, 2010 6:19 am | News | Comments

Abbott Laboratories said its net income was unchanged in the second quarter as greater expenses canceled out higher revenue from Abbott's drugs and medical devices and from companies it recently acquired.

TOPICS:
Advertisement

Integrated Raman Imaging System

July 20, 2010 8:36 am | Product Releases | Comments

Veeco Instruments Inc. announces the release of the IRIS models for Innova and BioScope Catalyst atomic force microscopes to provide superior integration and accessibility for combined atomic force microscopy and Raman spectroscopy research.

TOPICS:

Magnetic Beads

July 20, 2010 8:29 am | Product Releases | Comments

AMSBIO has announced a new range of MagSi magnetic beads that incorporate a novel ferro fluid to combine the advantages of small beads and large surface with the magnetic performance and strength of larger beads.

TOPICS:

Pharsight Names 5 Phoenix Centers of Excellence

July 20, 2010 8:11 am | News | Comments

Pharsight has named five leading universities as Phoenix Centers of Excellence as part of its continuing collaboration with academic departments and research organizations worldwide.

TOPICS:

J & J Posts 7.5% Increase in Earnings

July 20, 2010 8:06 am | News | Comments

Healthcare giant Johnson & Johnson posted a 7.5 percent increase in second-quarter income despite ongoing recalls of popular nonprescription medicines keeping sales flat.

TOPICS:

ZIOPHARM Begins Phase 3 Sarcoma Trial

July 20, 2010 8:03 am | News | Comments

ZIOPHARM Oncology, Inc. announced the initiation of the pivotal Phase 3 clinical trial for palifosfamide (Zymafos) in patients with front-line metastatic soft tissue sarcoma.

TOPICS:
Advertisement

Phase 3 Tapentadol Study Finds Fewer GI Problems

July 20, 2010 7:45 am | News | Comments

A Phase 3 open-label study, recently published online, has compared tapentadol extended release (ER) tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release (CR) tablets.

TOPICS:

New Technique Could Increase Power of Antivirals

July 20, 2010 7:39 am | News | Comments

Scientists have developed a new way to target viruses which could increase the effectiveness of antiviral drugs. Instead of attacking the virus itself, the method developed at the University of Edinburgh alters the conditions which viruses need to survive and multiply.

TOPICS:

New Understanding of Role of Estrogen-Like Compounds

July 20, 2010 7:35 am | News | Comments

Cancer researchers have discovered a previously unknown type of gene regulation and DNA behavior in breast cancer cells that may lead to better insight about environmental exposure to estrogen-like compounds.

TOPICS:

Ecstasy Effective As PTSD Treatment

July 20, 2010 7:30 am | News | Comments

Results of a recently published clinical trial suggests that MDMA can be administered to subjects with PTSD without evidence of harm and could offer sufferers a vital window with reduced fear responses where psychotherapy can take effect.

TOPICS:

FDA Panel May Withdraw Avastin Indication

July 20, 2010 6:59 am | News | Comments

Federal health advisers will vote on whether to withdraw regulatory approval of the Roche drug Avastin for breast cancer treatment after the drug showed disappointing results in recent studies.

TOPICS:

Ramius Attempting Buyout of Cypress Bioscience

July 20, 2010 6:50 am | News | Comments

Ramius LLC has offered to buy Cypress Bioscience in an all-cash deal. Ramius already owns 9.9 percent of Cypress and said it would buy the rest of the company for $4 per share as it lashed out at the management.

TOPICS:

Vaginal Gel Helps Prevent AIDS

July 20, 2010 6:31 am | by Marilynn Marchione | News | Comments

For the first time, a vaginal gel has proved capable of blocking the AIDS virus: It cut in half a woman's chances of getting HIV from an infected partner in a study in South Africa. Scientists called it a breakthrough in the long quest for a tool to help women whose partners won't use condoms.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading